Positive list system baffles drug makers

Concerns are mounting among drug makers over the so-called positive list system that may affect their export drive of generic drugs, although they are spending huge investments to construct or upgrade their GMP (good manufacturing practices) facilities.

Following the ratification of free trade agreement (FTA), Korean pharmaceutical firms will be able to bet on the possibility of mutual recog...